Vaso-Occlusive Pain Management in a Patient With Sickle Cell Disease Associated With Moyamoya Syndrome

被引:0
|
作者
Mills, Drezelle [1 ,2 ]
Wang, Annie [3 ]
Dubson, Iya [2 ]
机构
[1] St Georges Univ, Internal Med, Sch Med, St Georges, Grenada
[2] Kings Cty Hosp Ctr, Internal Med, Brooklyn, NY 11203 USA
[3] State Univ New York Downstate Hlth Sci Univ, Internal Med, Brooklyn, NY USA
关键词
pain management; vaso-occlusive pain; hypotension; sickle cell disease; moyamoya syndrome;
D O I
10.7759/cureus.23667
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Moyamoya syndrome in a sickle cell disease patient may be a difficult task to manage in the setting of a vaso-occlusive pain crisis. Maintaining stable blood pressure is necessary to prevent stroke as both hypertension and hypotension can be detrimental to the patient, leading to hemorrhagic and ischemic stroke, respectively. Opioid management for pain control in such patients must be taken into consideration. Because every patient is unique, opioid regimens should he optimized to relieve patients' specific pain while also practicing non-maleficence in preventing hypotension and strokes.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Management of vaso-occlusive pain in children with sickle cell disease
    Jacob, E
    Miaskowski, C
    Savedra, M
    Beyer, JE
    Treadwell, M
    Styles, L
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (04) : 307 - 311
  • [2] ACUTE MANAGEMENT OF VASO-OCCLUSIVE PAIN IN PEDIATRIC SICKLE CELL DISEASE
    Freed, Jennifer
    Ender, Katherine L.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 727 - 727
  • [3] The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management
    Darbari, Deepika S.
    Sheehan, Vivien A.
    Ballas, Samir K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (03) : 237 - 246
  • [4] A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease
    Harris, Emily M.
    Vilk, Emily
    Heeney, Matthew M.
    Solodiuk, Jean
    Greco, Christine
    Archer, Natasha M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [5] Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease
    Harris, Emily M.
    Vilk, Emily
    Donado, Carolina
    Williams, Alexis
    Heeney, Matthew M.
    Solodiuk, Jean
    Greco, Christine
    Archer, Natasha M.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (05)
  • [6] State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease
    Latika Puri
    Kerri A. Nottage
    Jane S. Hankins
    Doralina L. Anghelescu
    Pediatric Drugs, 2018, 20 : 29 - 42
  • [7] State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease
    Puri, Latika
    Nottage, Kerri A.
    Hankins, Jane S.
    Anghelescu, Doralina L.
    PEDIATRIC DRUGS, 2018, 20 (01) : 29 - 42
  • [8] Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management
    Uwaezuoke, Samuel N.
    Ayuk, Adaeze C.
    Ndu, Ikenna K.
    Eneh, Chizoma I.
    Mbanefo, Ngozi R.
    Ezenwosu, Osita U.
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 3141 - 3150
  • [9] Ketamine Use for Management of Vaso-Occlusive Pain in Children with Sickle Cell Disease
    Harris, Emily M.
    Vilk, Emily
    Donado, Carolina
    Williams, Alexis
    Heeney, Matthew M.
    Solodiuk, Jean
    Greco, Christine
    Archer, Natasha M.
    BLOOD, 2022, 140 : 5435 - 5436
  • [10] Sickle Cell Disease and Pain Is it all Vaso-occlusive Crises?
    Ramsay, Zachary
    Bartlett, Rachel
    Ali, Amza
    Grant, Justin
    Gordon-Strachan, Georgiana
    Asnani, Monika
    CLINICAL JOURNAL OF PAIN, 2021, 37 (08): : 583 - 590